Objectives. To compare the trabecular bone score (TBS) between patients with axial spondyloarthritis (axSpA) and matched normal controls and identify risk factors associated with a low TBS.
Introduction
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease that primarily affects the axial skeleton. AxSpA includes patients with structural damage in the sacroiliac joints or spine visible on radiographs (radiographic axSpA, or AS) and also patients without such structural damage, defined as non-radiographic axSpA (nr-axSpA). Patients present with chronic inflammatory pain, predominantly of the pelvis and lower back. Inflammation and structural damage can occur in the axial skeleton as a consequence of inflammation [1] .
SpA exerts a paradoxical situation with respect to bone metabolism as it is associated with generalized bone loss (osteoporosis), as well as localized inflammatory bone resorption and new bone formation, such as syndesmophytes. It has been established that generalized bone loss may be due to systemic inflammation and disease activity. Increased inflammation and pro-inflammatory cytokines have been implicated in the development of secondary osteoporosis [2] . Bone mineral density (BMD) and fracture risk in axSpA patients are lower and higher, respectively, than in age-and sex-matched general populations [3, 4] .
Osteoporosis is a skeletal disorder characterized by compromised bone strength, which predisposes with this disease to an increased risk of fracture. Bone strength can be considered to be primarily determined by bone density and quality (e.g. microarchitecture) [5] . A deterioration of trabecular microarchitecture with loss of connectivity between trabeculae and cortical thinning is typically observed in patients with osteoporosis [6] . Increased fracture risk in axSpA is likely to be multifactorial, resulting from traditional osteoporosis risk factors and diseaserelated factors such as systemic inflammation, which affects not only BMD, but also bone quality properties [7, 8] .
It is unclear which imaging approach is most effective for diagnosing and monitoring osteoporosis in axSpA. DXA measurement of BMD at the hip and spine is most often used to establish or confirm a diagnosis of osteoporosis and to monitor patients [9] . Most data related to bone loss in AS are also based on studies using DXA measurement of BMD. However, defining osteoporosis using DXA has several limitations, including the confounding effects of the surrounding soft tissue, bone artifacts caused by osteoarthritis, degenerated discs, aortic calcification and vertebral compression fractures. Syndesmophytes, as a result of inflammation, may increase BMD as measured by DXA despite the presence of osteoporosis. BMD may, therefore, not be an optimal marker for diagnosing osteoporosis in patients with axSpA. In addition, DXA cannot be used to measure bone microarchitecture or quality, which are believed to influence fracture risk [6] . In patients with axSpA, bone microarchitecture alterations, as well as BMD reduction, might be responsible for the increased risk of fractures. Quantitative CT (QCT) and high resolution peripheral QCT (HR-pQCT) have been developed to measure bone microarchitecture and assess bone quality. Although evidence suggests that these methods can predict fracture, they are not routinely available in practice [10] . Therefore, a clinically available, non-invasive technique for the accurate evaluation of bone microarchitecture in axSpA is required.
The trabecular bone score (TBS) is a novel tool used to evaluate bone microarchitecture. It is a textural index that evaluates pixel grey-level variations in the lumbar spine DXA image, thereby providing an indirect index of trabecular microarchitecture [11] . The TBS derived from DXA images correlates with the 3D microarchitecture parameters measured by QCT [12] . A previous study showed that TBS is not influenced by spinal osteophytes, which may lead to an overestimation of BMD among patients with lumbar spine OA [13] . This suggests that TBS can assess the bone microarchitecture among patients with axSpA regardless of syndesmophytes.
To date, no studies have compared TBS between patients with axSpA and matched controls. Therefore, the present study was conducted to assess TBS in these two groups and to identify the risk factors related to a low TBS in patients with axSpA.
Methods

Study population
Between August 2013 and December 2016, consecutive axSpA patients from Incheon St Mary's Hospital (Incheon, Korea) were recruited to this casecontrol study. All enrolled patients fulfilled the imaging arm of the Assessment of SpondyloArthritis International Society (ASAS) axSpA criteria [14] . All patients were aged between 20 and 69 years, and all female patients were premenopausal. Age-and sex-matched subjects who attended routine health check-up examinations during the same period were recruited as controls. Exclusion criteria included patients or controls with thyroid or parathyroid disorders, presence of chronic renal or liver disease, and use of corticosteroid, calcium or bisphosphonate agents. No one received vitamin D agents.
TBS and BMD were assessed at the time of enrolment. At the time of TBS assessment, demographic data were collected, osteoporosis risk factors were assessed (smoking status and alcohol consumption) and ESR and CRP were measured. All participants provided written consent according to the Declaration of Helsinki. The study was approved by the ethics committee at Incheon St Mary's Hospital (study number: OC16OISI0138).
Clinical data
In patients with axSpA, disease-related data and disease activity scores were collected. Clinical data included time after symptom onset, the presence of HLA B27, family history and the use of medications such as anti-inflammatory drugs, SSZ and TNF inhibitors. Measures of disease activity were collected using the BASDAI [15] . All scores were recorded on a visual analogue scale from 0 to 10. The BASFI [16] and patient global assessment scores were also recorded. The ASDAS was calculated as described previously [17] .
BMD assessment
Areal BMD was measured at the lumbar spine (L1L4) and left hip using DXA (Lunar Prodigy densitometer, GE Healthcare, Madison, WI, USA). All measurements were taken by experienced operators using the same machine and standardized procedures for participant positioning. BMD was measured at the lumbar spine (L1L4) and the left hip (femoral neck and total proximal femur) and expressed as the number of grams of bone mineral per square centimetre (g/cm 2 ).
TBS assessment TBS was analysed using DXA images of the lumbar spine (L1L4). Lumbar spine DXA images were reanalysed in an operator-independent automated manner using TBS iNight software version 2.1 (Med-Imaps, Merignac, France). The software uses the posterioranterior images, including the BMD region of interest and edge detection; thus the TBS is calculated over exactly the same region as the lumbar BMD assessment. Patients in the axSpA group were divided into three TBS groups according to the risk of fracture in a recent meta-analysis; high risk: TBS below 1.23; medium risk: TBS 1.231.31; low risk: TBS above 1.31 [18] .
Radiographic scoring
For all patients, radiographs of the cervical spine, lumbar spine and pelvis were obtained at the time of the TBS assessment. Lateral views of the cervical and lumbar spine were scored according to the modified Stoke AS Spinal Score (mSASSS) [19] . Sacroiliitis was scored from right and left sided pelvic radiographs using the modified New York criteria [20] . The average score for both sides was used for analysis. Sacroiliitis and the mSASSS were scored by a single trained expert who was blinded to the patient characteristics.
Statistical analysis
Statistical analyses were performed using SPSS Statistics (version 21.0; IBM Corp., Armonk, NY, USA). Continuous data were expressed as the mean (S.D.), and categorical data were expressed as percentages. Clinical variables were compared using an independent t test, and the chi-squared test was used to compare categorical variables between axSpA patients and matched control subjects. Spearman's correlation coefficient was used to analyse the correlation between variables. Clinical variables, and BMD and TBS values were compared in TBS subgroups across fracture risk using chi-squared tests for categorical variables and analysis of variance tests for continuous data.
Multiple linear regression models were used to assess the association between TBS and clinical variables in the axSpA group. All variables with a P < 0.05 in univariate linear regression analyses were incorporated as explanatory variables (enter method). In the multivariate analysis, separate models for baseline ESR and CRP were performed due to multicollinearity. P < 0.05 was considered statistically significant.
Results
Patient characteristics
Both study groups recruited 248 subjects, the demographic and clinical characteristics of which are shown in Table 1 . The mean age of the patients in both groups was 39 (11) years, and 78% were male.
There were no significant differences between the groups in terms of BMI, smoking history, alcohol consumption, diagnosis of diabetes mellitus, hypertension or treatment with lipid-lowering agents. ESR, CRP and platelet levels were higher in the axSpA group than in controls (P < 0.001, P < 0.001 and P = 0.013, respectively). Haemoglobin levels were lower in the axSpA group than in matched controls (P = 0.002). Among the 248 patients with axSpA, 207 fulfilled the modified New York criteria for AS [20] . The mean symptom duration was 10 (9) years, and 215 (87%) were HLA B27 positive. The mean BASDAI and ASDAS-CRP scores were 4.1 (2.2) and 2.4 (1.3). The average grade of sacroiliitis on X-ray and mSASSS was 2.9 (1.0) and 13.1 (20.0), respectively. Of the 248 patients, 108 (44%) had one or more syndesmophytes. The majority of patients (93%) received NSAIDs, and 21% received TNF inhibitors.
Assessment of TBS and BMD
The mean TBS value was 1.43 (0.08) for controls and 1.38 (0.12) for axSpA patients (P < 0.001; Fig. 1A) . BMD data are shown in Fig. 1B . BMD at the lumbar spine did not differ between the two groups. The mean BMD at the femoral neck was 0.98 (0.14) in controls and 0.93 (0.13) in the axSpA group; the mean BMD of total hip was 1.03 (0.14) in controls and 0.97 (0.14) in the axSpA group (both P < 0.001).
Correlation between clinical data, inflammatory markers, BMD and TBS In both groups, the TBS showed a significant negative correlation with age and positive correlation with BMD of lumbar spine, femoral neck and total hip ( Table 2 ). The TBS was negatively correlated with ESR and CRP in the axSpA group only.
Comparisons of TBS and BMD according to the presence of syndesmophytes As shown in Fig. 2 , TBS values were significantly lower in axSpA patients with and without syndesmophytes than in matched controls (P = 0.004 and P < 0.001, respectively). Lumbar spine BMD was significantly lower in the axSpA group without syndesmophytes than in the controls [1.13 (0.14) vs 1.18 (0.15) in controls; P = 0.008]. In contrast, the mean lumbar spine BMD was higher in the axSpA group with syndesmophytes [1.26 (0.28) vs 1.19 (0.16) in controls; P = 0.021].
AxSpA patient characteristics stratified according to TBS fracture risk groups Table 3 shows the demographic characteristics and disease-related variables between three TBS subgroups according to the risk of fracture [18] . Factors associated with a higher risk were male sex (P = 0.028) and higher BMI (P = 0.029). There were no significant differences among the TBS subgroups of patients in the fracture risk with respect to age, smoking status, alcohol consumption, symptom duration and HLA B27 status. Serum ESR and CRP were higher in the axSpA group with high fracture risk TBS values than in the group with low risk (P = 0.013 and P = 0.034, respectively). BASDAI, ASDAS-ESR and ASDAS-CRP did not differ between the three groups. The grade of sacroiliitis on X-ray, the mSASSS and the mean number of syndesmophytes were higher in patients with high fracture risk TBS (P = 0.006, P < 0.001 and P < 0.001, respectively). BMD levels at the lumbar spine did not differ between the three groups, although significant differences in BMD of the femoral neck and total hip were seen (P = 0.003 and P = 0.015, respectively).
Linear regression analysis for TBS among axSpA patients Table 4 shows the results of univariate and multivariate analyses of TBS in the axSpA group. Univariate analysis revealed that TBS was associated with age, current smoking status, HLA B27, ESR, CRP, the grade of sacroiliitis and the mSASSS. In the multivariate analyses, ESR, CRP and mSASSS were significantly associated with the TBS value.
Discussion
In the present study, TBS was used to assess bone microarchitecture and investigate the relationship between systemic inflammation, radiographic progression and bone quality in patients with axSpA. When assessed by TBS, patients with axSpA were seen to have poor bone quality in the lumbar spine compared with matched controls. Markers of systemic inflammation, such as ESR or CRP, correlated with TBS in patients with axSpA, but not in controls. Also, systemic inflammatory markers and spinal radiographic progression scores were independently associated with low TBS. AxSpA is characterized by ossification of the entheses and formation of syndesmophytes, but paradoxically there is also loss of trabecular bone adjacent to sites of inflammation. Trabecular and cortical compartments appear to have different reactions to inflammation; in AS, inflammation has a direct effect on the trabecular bone of the vertebrae, but not the cortical bone [21] , and therefore AS patients show low trabecular BMD in the spine QCT [8] . DXA-based BMD cannot distinguish between cortical and trabecular compartments and cannot reflect trabecular bone microarchitecture alterations, and therefore potentially result in inconsistent data in patients with AS [2224] . TBS has the advantage of being able to directly assess the microarchitecture of trabecular bone at the lumbar spine, which is the main area of involvement in axSpA patients. A previous study showed that sacroiliitis on MRI correlates with BMD at the femoral neck and total hip; however, sacroiliitis on MRI was not associated with lumbar BMD [25] . This indicates that bone loss at the spine in axSpA patients may be due to the localized effects of inflammation.
Our data showed that BMD at the lumbar spine did not differ between axSpA and non-axSpA subjects despite differences in bone microarchitecture measured by TBS. This may be related to both an overestimation of BMD due to the presence of syndesmophytes and insufficient reflection of changes in the quality of trabecular bone caused by chronic inflammation. In the subgroup analysis according to the presence of syndesmophytes, we found that the presence of syndesmophytes was associated with lower TBS but higher BMD in the lumbar spine. This result is consistent with earlier studies also reporting lower trabecular volumetric BMD measured by QCT but higher cortical volumetric BMD in AS [8, 26] . The EULAR taskforce made a series of recommendations with respect to the use of imaging for the management of SpA. They proposed that, in patients with axSpA without syndesmophytes in the lumbar spine on conventional radiography, osteoporosis should be assessed using hip DXA and anteriorposterior spine DXA; in patients with syndesmophytes in the lumbar spine on conventional radiography, osteoporosis should be assessed using hip DXA supplemented by either spine DXA (lateral projection) or possibly QCT of the spine [27] . Although spinal DXA using a lateral view has the advantage of allowing selection of a trabecular zone in the centre of the vertebral bodies, it has poor precision due to the difficulty in positioning the patients. Moreover, due to the overlap of the last rib and iliac crest, only L3 can be measured in some cases [13, 28] . QCT cannot be performed routinely in a clinical setting due to the high radiation dose required, cost and limited access to such devices [10] . Therefore, a tool that is unaffected by spinal progression is needed to assess osteoporosis and to predict fracture risk in axSpA. Our findings indicate that TBS may be a valuable alternative tool for the assessment of bone quality influenced by inflammation in patients with axSpA, regardless of spinal progression. A recent small study also showed that TBS is not affected by syndesmophytes in patients with axSpA [29] . Including the assessment of bone quality using TBS, as well as BMD measurement, may improve the predictive value for the development of new vertebral fractures.
The data presented here also show that ESR and CRP levels were independently associated with TBS after adjusting for confounding factors. In contrast with ESR and CRP, we found that BASDAI and ASDAS did not correlate with TBS. In general, clinical disease activity scores such as BASDAI and ASDAS comprise self-reported measures. These scores can be influenced by ankylosis and secondary changes in AS. Therefore, bony changes caused by inflammation may be more closely related to objective inflammatory markers than to clinical disease activity scores. The association between TBS and inflammatory markers suggests that in patients with axSpA TBS may reflect bone quality alteration in the presence of systemic inflammation. The correlation between TBS and inflammatory markers among axSpA patients suggests that TBS reflects inflammation-mediated changes in trabecular bone in the lumbar spine, and therefore, assessment of bone quality in the spine using the TBS may be a better predictor of the risk of osteoporosis and vertebral fracture in patients with axSpA. In addition, spinal radiographic progression score (mSASSS) was an independent risk factor for low TBS. Spinal radiographic progression reflects the severity of cumulative inflammation in the spine, and our data suggest that spinal radiographic progression may increase the risk of osteoporosis as it is associated with poor bone quality, as well as stiffening of the spine, in patients with axSpA. Longitudinal studies are required to examine whether the TBS is predictive of vertebral fracture.
Lumbar TBS is associated with an age-dependent variable, and a significant decrease in TBS has been observed with ageing in both male and female subjects [11, 30] . In the present study, age was negatively correlated with TBS in both the axSpA and control groups. In the axSpA group, age was associated with TBS in univariate analysis, but the association was not observed in multivariate analysis after adjusting for confounding factors. Therefore, it appears that TBS in axSpA is more influenced by the severity of systemic and local inflammation than ageing, and the strict control of inflammation may help to decrease the risk of osteoporosis among patients. This finding should be assessed further in prospective longitudinal studies.
This study has a few limitations. First, vitamin D and PTH were not measured. These variables are important for skeletal health and could affect the risk of osteoporosis. Second, only 52 (21%) patients received TNF inhibitors. This is a relatively small number when considered alongside the total number of axSpA patients; therefore, the regression analysis could be underpowered.
In conclusion, TBS assessment revealed poor bone quality in the lumbar spine in patients with axSpA when compared with matched controls. Systemic inflammatory markers were negatively correlated with TBS in axSpA and spinal radiographic progression, and inflammatory markers were independently related to low TBS. These data support the use of TBS as a useful clinical tool to identify the risk of osteoporosis in patients with axSpA.
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